ARS Pharmaceuticals Files 2025 Proxy Statement
Ticker: SPRY · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1671858
| Field | Detail |
|---|---|
| Company | Ars Pharmaceuticals, Inc. (SPRY) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
ARS Pharma's proxy statement is out for the June 25th shareholder meeting. Vote on directors & company stuff.
AI Summary
ARS Pharmaceuticals, Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting of stockholders scheduled for June 25, 2025. The filing, which is not an amendment, concerns the company's corporate governance and matters to be voted on by shareholders. ARS Pharmaceuticals, formerly Silverback Therapeutics, Inc., is based in San Diego, CA.
Why It Matters
This filing outlines the agenda for ARS Pharmaceuticals' shareholder meeting, detailing proposals and director elections that will shape the company's future direction and governance.
Risk Assessment
Risk Level: low — This is a routine annual proxy filing detailing upcoming shareholder meeting matters and does not contain new financial or operational information that would inherently increase risk.
Key Players & Entities
- ARS Pharmaceuticals, Inc. (company) — Registrant
- Silverback Therapeutics, Inc. (company) — Former company name
- June 25, 2025 (date) — Annual meeting date
- April 29, 2025 (date) — Filing date
- San Diego, CA (location) — Company headquarters
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information regarding the annual meeting of stockholders, including matters to be voted upon, director nominations, and other corporate governance details.
When is the ARS Pharmaceuticals annual meeting of stockholders scheduled?
The annual meeting of stockholders for ARS Pharmaceuticals is scheduled for June 25, 2025.
What was ARS Pharmaceuticals' former company name?
ARS Pharmaceuticals was formerly known as Silverback Therapeutics, Inc.
On what date was this definitive proxy statement filed?
This definitive proxy statement was filed on April 29, 2025.
Where is ARS Pharmaceuticals, Inc. located?
ARS Pharmaceuticals, Inc. is located at 11682 El Camino Real, Suite 120, San Diego, CA 92130.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding ARS Pharmaceuticals, Inc. (SPRY).